Device
Continuous non-invasive hemoglobin monitoring
Continuous non-invasive hemoglobin monitoring is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Phase Distribution
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
completed267%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
completed
Intraoperative Continuous Noninvasive Hemoglobin Monitoring in Patients Undergoing Thoracic Surgery
NCT07135492
unknownnot_applicable
Noninvasive and Continuous Hemoglobin Monitoring for Surgical Blood Management
NCT01686659
completednot_applicable
Impact of SpHb Monitoring on Transfusion
NCT01906515
Clinical Trials (3)
Showing 3 of 3 trials
NCT07135492
Intraoperative Continuous Noninvasive Hemoglobin Monitoring in Patients Undergoing Thoracic Surgery
NCT01686659Not Applicable
Noninvasive and Continuous Hemoglobin Monitoring for Surgical Blood Management
NCT01906515Not Applicable
Impact of SpHb Monitoring on Transfusion
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3